Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CASP1 | P29466 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CASP7 | P55210 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30762210 | 0.83 | ALDH1A1 (0.47) | ALDH1A1TDP1CASP1KDM4ESMN1; SMN2 | |
| SCHEMBL18353675 | 0.83 | ALDH1A1 (0.47) | ALDH1A1TDP1CASP1KDM4ESMN1; SMN2 | |
| SCHEMBL1362307 | 0.82 | SKP2 (0.57) | ALDH1A1TDP1KDM4ESMN1; SMN2MAPT | |
| SCHEMBL6867025 | 0.81 | ALDH1A1 (0.54) | ALDH1A1TDP1CASP1KDM4ESMN1; SMN2 | |
| SCHEMBL17471726 | 0.79 | SKP2 (0.50) | ALDH1A1TDP1CASP1KDM4ESMN1; SMN2 | |
| SCHEMBL8211010 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TDP1CASP1KDM4ESMN1; SMN2 | |
| SCHEMBL5005675 | 0.79 | TDP1 (0.52) | ALDH1A1TDP1CASP1KDM4ESMN1; SMN2 | |
| SCHEMBL93048 | 0.78 | S1PR1 (0.47) | ALDH1A1CYP3A4TSHRHSD17B10CYP1A2 | |
| SCHEMBL29803246 | 0.78 | MEN1 (0.44) | ALDH1A1TDP1KDM4ESMN1; SMN2MAPT | |
| SCHEMBL866022 | 0.78 | MEN1 (0.44) | ALDH1A1TDP1KDM4ESMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 394 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3911795-B1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2025-10-01 | — | — | EP | claimed |
| CN-113646479-B | Method for strengthening non-keratin fibers and use thereof | 埃斯普投资有限公司 | 2023-06-13 | — | — | CN | claimed |
| US-20220120031-A1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2022-04-21 | — | — | US | claimed |
| EP-3911795-A1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP Investments LLC (US) | 2021-11-24 | — | — | EP | claimed |
| CN-113646479-A | Method for strengthening non-keratin fibers and use thereof | 埃斯普投资有限公司 | 2021-11-12 | — | — | CN | claimed |
| EP-3565523-B1 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | HERCULES LLC (US) | 2021-09-08 | — | — | EP | claimed |
| WO-2020150384-A1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2020-07-23 | — | — | WO | claimed |
| EP-3565523-A1 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | Hercules LLC (US) | 2019-11-13 | — | — | EP | claimed |
| EP-1773768-B1 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS INC (US) | 2018-08-22 | — | — | EP | claimed |
| US-20180193242-A1 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | HERCULES LLC (DE) | 2018-07-12 | — | — | US | claimed |
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2006-05-25 | — | — | US | claimed |
| WO-2006012642-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS, INC. (US) | 2006-02-02 | — | — | WO | claimed |
| CN-1558898-A | Antiviral agent | ��Ұ����ҩ��ʽ���� | 2004-12-29 | — | — | CN | claimed |
| US-6835212-B2 | Compound with a nucleophilic reaction center, aryl alcohol or benzyl alcohol derivatives and an oxidizing enzyme | WELLA AKTIENGESELLSCHAFT (DE) | 2004-12-28 | — | — | US | claimed |
| EP-1422218-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2004-05-26 | — | — | EP | claimed |
| EP-1341503-A2 | AGENT AND METHOD FOR DYEING KERATIN FIBRES | Wella Aktiengesellschaft (DE) | 2003-09-10 | — | — | EP | claimed |
| US-20030041391-A1 | Agent and method for dyeing keratin fibres | Wella GmbH (DE) | 2003-03-06 | — | — | US | claimed |
| US-6509393-B2 | Phase change inks | XEROX CORPORATION | 2003-01-21 | — | — | US | claimed |
| US-20020137816-A1 | Phase change inks | XEROX CORPORATION | 2002-09-26 | — | — | US | claimed |
| WO-2002047633-A2 | AGENT AND METHOD FOR DYEING KERATIN FIBRES | WELLA AKTIENGESELLSCHAFT (DE) | 2002-06-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | PTGS2, PTGES2, PTGES | ALDH1A1 483/4885TDP1 3288/4885CASP1 2021/4885 |
| US-20180193242-A1 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | FHIT, KAT2B, KAT2A | ALDH1A1 291/4885TDP1 3444/4885CASP1 3875/4885 |
| US-20030041391-A1 | Agent and method for dyeing keratin fibres | KRT18, AKR7A2, ADH5 | ALDH1A1 27/4885TDP1 1852/4885CASP1 2411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.